|
Author: Coghlan JG, Schrieber B. Date Published: January-2012 Source: Current Rheumatology Reports
Pulmonary arterial hypertension associated with scleroderma (SScPAH) is a debilitating, highly lethal condition that responds to an array of therapies. Quality of life and prognosis are substantially improved by treatment, and early diagnosis and treatment are associated with improved outcomes.
|